Lm. Baddour et al., RISK FACTOR ASSESSMENT FOR THE ACQUISITION OF FLUOROQUINOLONE-RESISTANT ISOLATES OF PSEUDOMONAS-AERUGINOSA IN A COMMUNITY-BASED HOSPITAL, Microbial drug resistance, 1(3), 1995, pp. 219-222
A case-control study was performed in a community-based nonteaching ho
spital to assess patient risk factors for the acquisition of fluoroqui
nolone-resistant isolates of Pseudomonas aeruginosa. Fifty-five patien
ts who were hospitalized between July 1, 1993 and December 31, 1993 an
d who had P. aeruginosa recovered from a clinical specimen were includ
ed in the analysis. Two patient populations were designated based on t
he fluoroquinolone susceptibility of their P. aeruginosa isolates. Sta
tistical evaluation using univariate analysis of demographic and clini
cal data from the 42 patients with quinolone-susceptible P. aeruginosa
and the 13 patients with quinolone-resistant P. aeruginosa demonstrat
ed that prior receipt of a fluoroquinolone was the only significant ri
sk factor for the subsequent emergence of fluoroquinolone resistance a
mong P. aeruginosa isolated from patients hospitalized in this small c
ommunity-based institution (p = 0.0196), Multivariate analysis support
ed the finding that prior receipt of a fluoroquinolone was the major r
isk factor for the isolation of fluoroquinolone-resistant P. aeruginos
a (p = 0.0004); isolation of this Gram-negative bacillus from sputum (
p = 0.0306) and a history of recent surgery (p = 0.0058) were also sig
nificantly associated as risk factors for resistance.